Cancer Therapy

Patent issued for method to predict effectiveness of chemotherapy

Published in Cancer Weekly, August 3rd, 2004

U.S. Patent and Trademark Office granted patent gene methylation technology for the prediction of clinical response to certain types of chemotherapeutic treatment of cancer patients.

The treatment was developed by researchers at The Johns Hopkins Kimmel Cancer Center. OncoMethylome Sciences is the exclusive licensee of this patent, as well as of other key patents in the field of gene methylation technology.

Alkylating agents are used for the treatment of various cancers including tumors of the brain, nervous system and lymph system. Their function is to damage tumor-cell DNA resulting in cell death. However, cells are normally protected by enzymes...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2004-08-03)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry